anti-pp50 (aa245-253) TCR, pCDTCR1(TCR-L095Z)
The vector of anti-pp50 T cell receptor (TCR) is constructed for the engineering of T cell to target CMV pp50. The T cells are genetically modified through transduction with a retroviral vector expressing pp50-specific T cell receptor.
Codon optimized and cysteine modified TCR
CMV pp50 peptide
65 kDa matrix phosphoprotein; 65 kDa phosphoprotein; Tegument protein pp65; Tegument protein UL83; TCR; T cell receptor; transgenic TCR; antigen-specific T cell receptors; Engineering T-cell receptors; recombinant t cell receptors; specific t cell receptor; modified t cell receptor; retroviral vector; Cytomegalovirus infection
CMV pp50 peptide VTEHDTLLY (HLA-A*0101) for stimulation of T-cells. Single peptide (VTEHDTLLY) for stimulation of human CMV pp50-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0101 allele. Lyophilized powder. Purity> 80 %, endotoxin free.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.